BSX BOSTON SCIENTIFIC CORP revenue, earnings and financials

For the quarter ended June 30, 2026, BOSTON SCIENTIFIC CORP reported revenue of $5.44B (up 7.5% from a year earlier), net income of $905M and diluted EPS of $0.61; over the last four quarters revenue was $21.0B and net income $3.67B; for the fiscal year ended December 2025 revenue was $20.1B, up 19.9% on the year before.

BSX annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $20.1B, gross profit $13.9B, operating income $3.61B, net income $2.89B (margin 14.4%), EPS $1.94
• Fiscal year ended Dec 2024: revenue $16.7B, gross profit $11.5B, operating income $2.60B, net income $1.85B (margin 11.0%), EPS $1.25
• Fiscal year ended Dec 2023: revenue $14.2B, gross profit $9.90B, operating income $2.34B, net income $1.59B (margin 11.2%), EPS $1.07
• Fiscal year ended Dec 2022: revenue $12.7B, gross profit $8.73B, operating income $1.65B, net income $698M (margin 5.5%), EPS $0.45
• Fiscal year ended Dec 2021: revenue $11.9B, gross profit $8.18B, operating income $1.20B, net income $1.04B (margin 8.8%), EPS $0.69

BSX quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $5.44B (up 7.5% year over year), net income $905M, EPS $0.61
• Quarter ended Mar 31, 2026: revenue $5.20B (up 11.6% year over year), net income $1.34B, EPS $0.90
• Quarter ended Dec 31, 2025 (from the annual report): revenue $5.29B (up 15.8% year over year), net income $670M, EPS $0.45
• Quarter ended Sep 30, 2025: revenue $5.07B (up 20.3% year over year), net income $755M, EPS $0.51
• Quarter ended Jun 30, 2025: revenue $5.06B (up 22.8% year over year), net income $795M, EPS $0.53
• Quarter ended Mar 31, 2025: revenue $4.66B (up 20.9% year over year), net income $672M, EPS $0.45
• Quarter ended Dec 31, 2024 (from the annual report): revenue $4.56B (up 22.5% year over year), net income $563M, EPS $0.38
• Quarter ended Sep 30, 2024: revenue $4.21B (up 19.3% year over year), net income $468M, EPS $0.32
• Quarter ended Jun 30, 2024: revenue $4.12B (up 14.5% year over year), net income $322M, EPS $0.22
• Quarter ended Mar 31, 2024: revenue $3.86B (up 13.8% year over year), net income $493M, EPS $0.33
• Quarter ended Dec 31, 2023 (from the annual report): revenue $3.73B (up 14.9% year over year), net income $504M, EPS $0.34
• Quarter ended Sep 30, 2023: revenue $3.53B (up 11.3% year over year), net income $504M, EPS $0.34
• Quarter ended Jun 30, 2023: revenue $3.60B (up 10.9% year over year), net income $270M, EPS $0.18
• Quarter ended Mar 31, 2023: revenue $3.39B (up 12.0% year over year), net income $314M, EPS $0.21
• Quarter ended Dec 31, 2022 (from the annual report): revenue $3.24B (up 3.7% year over year), net income $140M, EPS $0.09
• Quarter ended Sep 30, 2022: revenue $3.17B (up 8.1% year over year), net income $188M, EPS $0.12
• Quarter ended Jun 30, 2022: revenue $3.24B (up 5.4% year over year), net income $260M, EPS $0.17
• Quarter ended Mar 31, 2022: revenue $3.03B (up 10.0% year over year), net income $110M, EPS $0.07
• Quarter ended Dec 31, 2021 (from the annual report): revenue $3.13B, net income $95.0M, EPS $0.06
• Quarter ended Sep 30, 2021: revenue $2.93B, net income $419M, EPS $0.28

BSX cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow $4.53B, share buybacks n/a
• Fiscal year ended Dec 2024: operating cash flow $3.44B, share buybacks n/a
• Fiscal year ended Dec 2023: operating cash flow $2.50B, share buybacks n/a
• Fiscal year ended Dec 2022: operating cash flow $1.53B, share buybacks $0
• Fiscal year ended Dec 2021: operating cash flow $1.87B, share buybacks $0

BSX balance sheet

• Jun 30, 2026: cash $539M, total assets $45.2B, total liabilities n/a, shareholders' equity $24.9B
• Mar 31, 2026: cash $1.45B, total assets $44.4B, total liabilities n/a, shareholders' equity $25.9B
• Dec 31, 2025: cash $1.97B, total assets $43.7B, total liabilities n/a, shareholders' equity $24.2B
• Sep 30, 2025: cash $1.28B, total assets $42.7B, total liabilities n/a, shareholders' equity $23.4B
• Jun 30, 2025: cash $534M, total assets $41.6B, total liabilities n/a, shareholders' equity $22.4B
• Mar 31, 2025: cash $725M, total assets $40.1B, total liabilities n/a, shareholders' equity $22.2B
• Dec 31, 2024: cash $414M, total assets $39.4B, total liabilities n/a, shareholders' equity $21.8B
• Sep 30, 2024: cash $2.50B, total assets $38.1B, total liabilities n/a, shareholders' equity $20.7B

What is BSX's revenue?

BOSTON SCIENTIFIC CORP reported $21.0B of revenue over its last four quarters, through June 30, 2026.

Is BSX profitable?

Yes. BOSTON SCIENTIFIC CORP earned $3.67B over the last four quarters.

What is BSX's EPS?

Diluted earnings per share over the last four quarters were $2.47; $0.61 in the latest quarter.

BSX ownership and insider trades · All stocks